Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Ascelia Pharma AB

Closing information (x1000 SEK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 13,943 Less Arrow 2,418 More Arrow 3,965
Earnings before taxes -80,124 Less Arrow -109,607 Less Arrow -133,155
EBITDA -66,828 Less Arrow -109,865 Less Arrow -145,961
Total assets 140,920 Less Arrow 87,072 More Arrow 218,569
Current assets 83,718 Less Arrow 28,937 More Arrow 160,869
Current liabilities 61,976 Less Arrow 12,568 More Arrow 37,517
Equity capital 78,944 Less Arrow 74,328 More Arrow 180,859
- share capital 97,193 Less Arrow 34,871 Equal arrow 34,871
Employees (average) 11 More Arrow 23 Less Arrow 22

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 56.0% More Arrow 85.4% Less Arrow 82.7%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -47.0% Less Arrow -123.1% More Arrow -59.1%
Current ratio 135.1% More Arrow 230.2% More Arrow 428.8%
Return on equity (ROE) -101.5% Less Arrow -147.5% More Arrow -73.6%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -12 More Arrow 1 More Arrow 2
Chg. No. of employees % -52% More Arrow 5% More Arrow 10%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.